The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 06, 2025
Filed:
Jul. 13, 2022
Applicant:
Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);
Inventors:
Ana Kostic, New York, NY (US);
Ludmila Kelly, Silver Spring, MD (US);
Xia Liu, Hopewell Junction, NY (US);
Brendan J. Classon, Seattle, WA (US);
Allen Radin, New York, NY (US);
Assignee:
Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2005.12); A61K 9/00 (2005.12); A61K 31/56 (2005.12); A61K 39/00 (2005.12); A61K 39/395 (2005.12); A61K 45/06 (2005.12);
U.S. Cl.
CPC ...
C07K 16/2866 (2012.12); A61K 9/0019 (2012.12); A61K 31/56 (2012.12); A61K 39/3955 (2012.12); A61K 45/06 (2012.12); A61K 2039/505 (2012.12); A61K 2039/54 (2012.12); A61K 2039/545 (2012.12); A61K 2039/577 (2012.12); C07K 2317/21 (2012.12); C07K 2317/565 (2012.12); C07K 2317/76 (2012.12); C07K 2318/00 (2012.12);
Abstract
The present invention provides methods for treating, preventing or reducing the severity of eosinophilic esophagitis. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4Rα) inhibitor such as an anti-IL-4Rα antibody.